- Human CD8 T cells are purified from PBMCs of healthy blood donors sourced from a world-renowned blood center
- Highly enriched (typically >90%) post-selection purity achieved via negative isolation using magnetic columns
- Carefully cryopreserved to ensure high viability upon thawing
- All orders come with an iQ Certificate of Analysis
Purified Human CD8 T Cells
Human CD8 T Cells
Human CD8 T cells make up approximately 10-30% of PBMCs in a typical adult. These cells carry the CD8 protein marker and the T cell receptor (TCR), which recognizes foreign antigens presented by major histocompatibility complex class I molecules on antigen presenting cells to activate them.
CD8 T cells develop in the thymus to become mature T cells and exit the thymus to reside and encounter foreign pathogens in lymphoid tissues.
When activated, CD8 T cells become cytotoxic cells that can lyse infected or transformed cells.
CD8 T Cell Application Summary
Purified human blood T cells are a good source of cells to study the biology of CD8 T cells and their role in the immune system. They can be used for a variety of stimulation-dependent functional experiments to assess cytotoxicity and proliferation.
With the current trend toward development of immuno-modulatory drugs, CD8 T cells are an ideal source of cells to test cytotoxicity in the presence of therapeutic molecules.
The negative isolation of CD8 T cells leaves them untouched without any antibody binding to cell surface markers that may influence function. This method leaves all cell surface proteins eligible to be bound to antibodies or other molecules for functional or population characterization studies.
CD8 T Cell Purification
Collection of samples
Leukapheresis was performed on verified healthy donors at a world-renowned blood center to obtain PBMCs. PBMCs were carefully washed to remove excess buffers according to iQ Biosciences’ standard operating procedures to obtain clean and healthy PBMCs.
Negative Isolation of CD8 T cells
To purify our human CD8 T cells, PBMCs were incubated with antibodies against CD4 T cells, B cells, NK cells, dendritic cells, monocytes, granulocytes, and erythrocytes, and subsequently run through a magnetic column. Cells labeled with the antibodies were bound to the column, while unlabeled cells, the CD8 T cells, passed through.
A small aliquot of cells was tested for post-sort purity by flow cytometry analysis. Purity of CD8 T cells, as defined by CD8 expression, was > 95% (Figure 1).
Figure 1. Purity of CD8 T cells after selection by negative isolation using magnetic column separation from PBMCs. In this representation, human PBMCs were incubated with antibodies against CD4 T cells, B cells, NK cells, dendritic cells, monocytes, granulocytes, and erythrocytes and passed through a magnetic column to obtain CD8 T cells by negative selection. A small aliquot was taken after selection to evaluate post-sort purity (right). Percent of CD8+ cells in PBMCs is also shown (left).
Cryopreservation and storage
Purified CD8 T cells were cryopreserved carefully using iQ Biosciences’ cryopreservation protocol that ensures high viability after thawing.
Cells should be stored at <-120°C once they are received, such as within a liquid nitrogen tank (vapor phase).
Request a Cellular Products Fact Sheet for Human PBMCs
Interested in learning more about this Cellular Product? Complete the form below to request a Fact Sheet.
For US customers, we ship via FedEx Overnight Shipping. Shipping charges will vary per shipping address (based on ZIP code) and are estimated to be $110.
For international (non-US) customers, please submit an inquiry to email@example.com for your estimated time of delivery and shipping charges.